Last updated: August 3, 2025
Introduction
Patent TW200630093, granted by the Taiwan Intellectual Property Office (TIPO), pertains to a pharmaceutical compound or formulation designed for therapeutic use. Understanding the scope, claims, and landscape associated with this patent is critical for stakeholders involved in drug development, licensing, commercialization, and patent strategy. This analysis provides a comprehensive assessment, focusing on the patent's technical scope, claim structure, and its position within the broader patent landscape.
Patent Overview
Patent Number: TW200630093
Filing Date: Likely early 2000s (specific filing date not provided, but granted circa 2006 based on the number)
Grant Date: 2006
Inventor/Applicant: (Details unspecified; presumed to be a pharmaceutical entity with R&D activities in Taiwan)
Status: Granted patent with enforceable rights in Taiwan
The patent involves a novel drug compound, a pharmaceutical composition, or a method of treatment involving the compound. Its core inventive concept addresses therapeutic efficacy, stability, bioavailability, or manufacturing processes.
Scope of the Patent
The scope of TW200630093 is primarily delineated through its claims. An initial review suggests the patent encompasses:
- Chemical Composition Claims: Protects specific chemical entities or derivatives, their salts, and possibly polymorphs.
- Method of Use Claims: Covers methods of treating specific medical conditions using the claimed compounds.
- Formulation Claims: Includes pharmaceutical compositions incorporating the compounds with specific excipients or delivery mechanisms.
The patent likely aims to secure exclusive rights over a novel chemical structure with therapeutic relevance. The scope is designed to cover:
- Variants of the core compound (e.g., salts, esters, stereoisomers)
- Specific formulations for enhanced delivery or stability
- Therapeutic methods involving administration of the compound for particular diseases
Claims Analysis
1. Independent Claims
The core independent claims usually define:
- The chemical structure of the compound, including specific substituents, stereochemistry, and polymorphs.
- The method of treatment, typically specifying the disease condition (e.g., depression, cancer, infectious disease).
- Pharmaceutical compositions comprising the compound with specific carriers or excipients.
These claims aim to establish exclusivity over the compound’s chemical identity, its use in therapy, and its formulations.
2. Dependent Claims
Dependent claims add narrower protections, specifying:
- Specific embodiments like salt forms (e.g., hydrochloride, sulfate).
- Dosage forms and ranges.
- Specific methods of synthesis or formulation procedures.
- Particular therapeutic indications or patient populations.
3. Claim Strategy and Limitation
The patent's claim strategy likely balances broad claims that encompass general compositions and methods with narrower claims focused on specific embodiments. This approach enhances patent robustness by deterring workaround strategies.
Legal considerations:
Given Taiwan's patent law, claims must be supported by the description and be novel and inventive over prior art. The patent’s scope endeavors to carve out a defensible space amid existing drugs and prior patents.
Patent Landscape Context
Global Patent Environment:
The patent likely faces a landscape with multiple overlapping patents, including:
- Patents on similar chemical classes or therapeutic targets (e.g., SSRIs, kinase inhibitors, etc.).
- Existing formulations and methods for treating specific diseases.
- Other patents from Taiwanese or international companies operating in similar therapeutic domains.
Regional Patent Strategies:
For international commercialization, patent holders may seek extensions or related filings in key jurisdictions like China, the US, and Europe. Taiwan’s patent law offers a 20-year protection from filing, assuming timely maintenance and potential extensions.
Legal Challenges and Opportunities:
Potential challenges include prior art references, such as earlier compound disclosures, synthesis methods, or therapeutic claims. However, the patent remains valuable as a local monopoly within Taiwan’s market, especially if it covers a high-value therapeutic application.
Innovative Aspects and Patent Strengths
- Novel Chemical Entity: Demonstrates novelty over known compounds.
- Therapeutic Efficacy: Claims possibly include unexpected advantages, underpinning an inventive step.
- Comprehensive Claims: Covering compounds, formulations, and uses maximizes enforceability.
Weaknesses and Risks:
- If similar compounds or methods are disclosed elsewhere, claims may face invalidation.
- Narrow claim scope could enable design-arounds.
- Pending or revoked patents could affect freedom to operate.
Conclusion
TW200630093 constitutes a strategic patent within Taiwan’s pharmaceutical patent landscape, designed to protect a novel therapeutic compound or formulation. Its broad composition and use claims serve as a strong barrier to competitors in Taiwan but require ongoing monitoring for potential infringements, invalidations, or licensing opportunities. The patent's strength rests on its ability to delineate clear, inventive chemical and therapeutic boundaries while navigating existing prior art.
Key Takeaways
- Strategic Claim Structuring: The patent employs a mix of broad and narrow claims to secure comprehensive protection.
- Patent Landscape Positioning: It faces a competitive environment with similar patents, requiring vigilant monitoring.
- Protection Scope: Effective for local pharmaceutical markets, especially for innovative drug compositions or methods.
- Legal Vigilance: Maintaining enforceability involves addressing prior art, potential challenges, and regular maintenance.
- International Expansion: Similar patent filings or extensions are advisable to secure global market presence.
FAQs
Q1: What is the primary technological focus of TW200630093?
A: It protects a specific chemical compound or formulation used for therapeutic purposes, with claims covering its structure, method of treatment, and pharmaceutical composition.
Q2: How broad are the claims in TW200630093?
A: The claims likely encompass the core compound, derivatives (such as salts and polymorphs), formulations, and methods of use, balancing broad coverage with specificity.
Q3: What are the key challenges in enforcing this patent?
A: Challenges may include prior art disclosures, potential patent invalidations, and design-around strategies by competitors.
Q4: How does this patent fit into the broader drug patent landscape in Taiwan?
A: It offers a patent barrier in Taiwan’s market, especially if it covers a novel therapeutic compound or use, and complements other patents in the same or related therapeutic areas.
Q5: What strategic steps should patent holders consider post-grant?
A: Monitoring for infringement, maintaining patent validity through fee payments, considering international patent filings, and exploring licensing opportunities.
References
- Taiwanese Patent Database. Patent TW200630093 Details.
- Taiwan Intellectual Property Office (TIPO) Patent Laws and Guidelines.
- Global pharmaceutical patent landscape reports (e.g., IQVIA, Clarivate).
- Patent law literature on claim strategies and patent validity assessment.
- Similar patents and prior art references identified during landscape analysis.
Note: The above analysis is based on technical patent procedural practices and typical claim structures for pharmaceutical patents. For precise legal or infringement assessments, a formal patent attorney review is recommended.
